Johnston J M, Ihyer S R, Smith R S, Tai K F, Farmer T, Korsmeyer S J, Nadon N L, Carroll W L
Department of Pediatrics, University of Utah, Salt Lake City 84112, USA.
Eur J Immunol. 1996 May;26(5):1058-62. doi: 10.1002/eji.1830260515.
Somatic hypermutation of immunoglobulin (Ig) genes plays a critical role in the maturation of the human antibody response. The molecular basis of this important process is, however, unknown. To identify cis-acting sequences that initiate and target hypermutation, we have made three minitransgenes containing different portions of an Ig heavy chain (IgH) locus. Each transgene is a passenger, bearing a nonsense mutation preventing its translation; thus, transgene mutations reflect the endogenous mutational process and are not subject to affinity selection. To study transgenes after their circulation through the compartment associated with hypermutation in vivo, we rescued B cells as hybridomas after hyperimmunizing mice with the hapten 4-hydroxy-3-nitrophenyl acetyl (NP). Hybridoma transgene and endogenous variable regions were amplified by polymerase chain reaction, subcloned, and sequenced. Endogenous anti-NP VDJ regions show the expected, at times extensive degree of base substitution. In mice bearing the smallest construct, which includes 2.4 kb of 5' IgH sequences, a rearranged VDJ region, the 5' matrix attachment region, and the intron enhancer, one of four evaluable hybridomas demonstrates two base substitutions in the V segment of one transgene copy. The two larger constructs include additional 3' IgH sequences (an alpha constant region and the 3' enhancer) and either the original VDJ segment or a substituted T cell receptor beta segment. Ten hybridomas derived from mice bearing these larger constructs demonstrate no evidence of targeted mutation, despite demonstrable transgene transcription in all hybridomas. In our system, mutation of a rearranged VDJ segment and surrounding promoter/enhancer regions is not increased by the juxtaposition of a constant region segment and the IgH 3' enhancer.
免疫球蛋白(Ig)基因的体细胞超突变在人类抗体应答成熟过程中起关键作用。然而,这一重要过程的分子基础尚不清楚。为了鉴定启动和靶向超突变的顺式作用序列,我们构建了三个包含Ig重链(IgH)基因座不同部分的微型转基因。每个转基因都是一个携带无义突变从而阻止其翻译的乘客基因;因此,转基因突变反映了内源性突变过程,不受亲和力选择的影响。为了在转基因在体内经历与超突变相关的区室循环后对其进行研究,我们在用半抗原4-羟基-3-硝基苯基乙酰(NP)对小鼠进行超免疫后,将B细胞拯救为杂交瘤。通过聚合酶链反应扩增杂交瘤转基因和内源性可变区,亚克隆并测序。内源性抗NP VDJ区显示出预期的、有时是广泛的碱基替换程度。在携带最小构建体(包括2.4 kb的5'I gH序列、一个重排的VDJ区、5'基质附着区和内含子增强子)的小鼠中,四个可评估的杂交瘤之一显示一个转基因拷贝的V段中有两个碱基替换。两个较大的构建体包括额外的3'I gH序列(一个α恒定区和3'增强子)以及原始的VDJ片段或一个替代的T细胞受体β片段。尽管在所有杂交瘤中均可检测到转基因转录,但来自携带这些较大构建体的小鼠的十个杂交瘤均未显示靶向突变的证据。在我们的系统中,恒定区片段和IgH 3'增强子的并列并不会增加重排的VDJ片段及周围启动子/增强子区域的突变。